EL IMPACTO DEL DOLOR: DATOS EUROPEOS Y ESPAÑOLES

Transcripción

1 EL IMPACTO DEL DOLOR: DATOS EUROPEOS Y ESPAÑOLES César Margarit Unidad del Dolor Hospital General de Alicante Member of the Change Pain International Advisory Board

2 PARA PRODUCIR UN CAMBIO NATIONAL HEALTH AND WELLNESS SURVEY

3 ESQUEMA

4 EU (Big 5) Core Therapeutic Report

5 PROF. PAUL C. LANGLEY UNIVERSITY OF MINNESOTA Kantar Health. September 2010 NATIONAL HEALTH AND WELLNESS SURVEY, 2010 (EU) Princenton, NJ.

6 DATOS SEGMENTATION PROFILES

7 ANALISIS POR GRUPOS Key Analysis Groups RX Total EU (Big 5) Adultos Sin dolor el mes pasado Con dolor el més pasado Severo Moderado Leve OTC solo Sin tratamiento RX OTC solo Sin tratamiento RX OTC solo Sin tratamiento 7

8 CRITERIOS DE EXCLUSION

9 ESQUEMA

10 20%

11 TAMAÑO MUESTRAL EXPERIMENTARON DOLOR EN EL ULTIMO MES 11,40% 17,20% 30,20% 17,10% 24,00% FRANCE GERMANY UK ITALY SPAIN POBALCION ADULTA TOTAL EU: M POBLACION CON DOLOR : 52.7 M

12 PREVALENCIA DEL DOLOR(%)

13 EU (Big 5) Pain Prevalence 2010 Use Rx 80% Total EU (Big 5) Adult Population M (n=57,805) SEVERE (17%) OTC Only 12% Untreated 8% Experiencing Pain (in the past month)* 52.7 M (20%) (n=12,320) MODERATE (60%) Use Rx 52% OTC Only 29% Untreated 19% Use Rx 21% *Excludes dental problems, headache, menstrual pain or migraine only. MILD (23%) OTC Only 47% Untreated 32% 13

14 PREVALENCIA DEL DOLOR EN ESPAÑA 2010 Use Rx 80% Total poblacion adulta ESPAÑA 35.4 M ( SEVERO (12%) OTC Only 10% Untreated 10% Use Rx 66% DOLOR EN ULTIMO MES 6.1% (17.2%) MODERADO (64%) OTC Only 18% Untreated 16% Use Rx 37% *Excludes dental problems, headache, menstrual pain or migraine only. LEVE (24%) OTC Only 37% Untreated 25% 14

15 INTENSIDAD DEL DOLOR TOTAL 16,9 22,8 60,3 ITALY 10,6 23,8 66,31 FRANCE 14,1 26,7 59,2 SEVERE (%) SPAIN 11,7 24,1 64,2 MODERATE (%) MILD (%) GERMANY 12,5 26,2 61,3 UK 20,3 23,3 56,3 MODERATE

16 INTENSIDAD DEL DOLOR NHWS % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 22,8 16,9 59,2 60, ,8 NHWS 2008 NHWS 2010 SEVERE (%) MODERATE (%) MILD (%)

17 DISTRIBUCION POR EDADES EDAD MEDIA: 50.9

18 SEXO FEMALE MALE SEVERE MODERATE MILD TOTAL MAS MUJERES QUE HOMBRES

19 COMORBILIDADES PAIN CONDITION % EU / % ESPAÑA BACK PAIN 63/61 JOINT PAIN 48.0/40 NECK PAIN 29.6/29 ARTHRITIS PAIN 21.0/17 SPRAINS OR STRAINS 8.3/10 SURGERY OR MEDICAL PROCEDURE PAIN 6.7/7 FYBROMYALGIA PAIN 5.6 NEUROPATHIC PAIN 4.1 BROKEN BONE PAIN 3.9 CANCER PAIN 0.9 POST HERPETIC NEURALGIA 0.3

20 Tipo de condiciones que producen dolor Segun SEVERIDAD Severe (C) (714 K; n=100) Experiencing Pain (in the past month) * Moderate (D) (3.9 M; n=554) Mild (E) (1.5 M; n=214) Experience Pain (in the past month) * (6.1 M; n=868) Back pain 13% 67% 19% 61% Joint pain 15% 66% 19% 40% Neck pain 15% 66% 19% 29% Headache 12% 64% 24% 35% Arthritis pain 17% 66% 16% 17% Migraine 28% 57% 15% 12% Dental pain 15% 71% 14% 10% Sprains or strains 13% 57% 31% 10% Shoulder pain/stiffness 16% 67% 17% 23% Surgery or medical procedure 29% 63% 8% 7% *Excludes dental problems, headache, menstrual pain or migraine only. PN15: Please indicate which of the following conditions have caused you to feel pain in the past month. Letters indicate statistically significant 95% confidence level between subgroups 20

21 ESTADO LABORAL % MILD MODERATE SEVERE EMPLOYED NOT EMPLOYED

22 FRECUENCIA DEL DOLOR

23 FRECUENCIA DEL DOLOR + INTESIDAD TOTAL SEVERE MODERATE MILD Daily 4-6 times a week 2-3 times a week Once a week 2-3 times a month Once a month or less often

24 TRATAMIENTO DEL DOLOR PRESCRITO OTC SIN TRATAMIENTO 0 SEVERO 12 % MODERADO 64 % LEVE 24%

25 TRATAMIENTOS PRESCRITOS DOLOR SEVERO % , %

26 TRATAMIENTOS PRESCRITOS DOLOR MODERADO

27 TRATAMIENTOS PRESCRITOS DOLOR LEVE

28 Qué USAN A DEMANDA?

29 USO DE MEDICACION 87% de los pacientes con dolor han probado un tratamiento pautado El tratamiento prescrito se sigue cuanto más severo es el dolor AINE son comunes a todos los tipos de dolor Dolor severo: toman mas tiempo y de forma mas frecuente los tratamientos.

30 SATISFACCION CON EL TRATAMIENTO 56 A DEMANDA PRESCRITO LEVE MODERADO SEVERO

31 ADHERENCIA AL TRATAMIENTO SENTIRSE BIEN: NO ADHRENCIA

32 CUMPLIMIENTO TERAPEUTICO Medication Compliance (Among Experiencing Pain in the Past Month and using Pain medication) Severe - Rx Users (6.9 M; n=1,759) Moderate Rx Users (16.1 M; n=3,401) Mild - Rx Users (2.4 M; n=516) Take the exact amount prescribed by my doctor Take less than the amount prescribed by my doctor Take more than the amount prescribed by my doctor 32

33 COMORBILIDADES

34 ESQUEMA

35 CALIDAD DE VIDA(HRQoL) SF 12 v2: Proporciona dos indices de respuestas SALUD MENTAL(MCS) SALUD FISICA(PCS) CALIDAD DE VIDA GLOGAL(CALIDAD AJUSTADA POR AÑOS VIVIDOS): SF 6D. COMPARA LA POBLACION GENERAL CON LOS GRUPOS A ESTUDIO

36 CONCEPTOS DE SALUD DEL SF12

37 ESTADO DE SALUD LA POBLACION CON DOLOR ES MAS PESIMISTA

38 QoL

39 HRQoL

40 HRQoL

41 HRQoL: The moderate and severe pain population reports significantly lower Quality of Life Scores Physical Health Summary (SF12) Physical Health Summary (SF12) Adultos Hypertension Severo Atrial fibrillation Exp. Pain (in the past month) Moderado Prostate Cancer Leve Colorectal Cancer A difference of 3 points is clinically significant

42 HRQoL: The moderate and severe pain population reports significantly lower Quality of Life Scores Mental Health Summary (SF12) Mental Health Summary (SF12) Adults Hypertension Severo Atrial fibrillation Exp. Pain (in the past month) Moderado Prostate Cancer Leve Colorectal Cancer A difference of 3 points is clinically significant

43 LABOR FORCE PARTICIPATION AND PRODUCTIVITY 20%

44 PRODUCTIVIDAD LABORAL Y ESCALA DE AFECTACION DE LA PRODUCTIVIDAD

45 LABOR FORCE PARTICIPATION AND PRODUCTIVITY

46 LABOR FORCE PARTICIPATION AND PRODUCTIVITY

47 POBLACION ACTIVA

48 IMPACTO DEL DOLOR EN EL USO DE RECURSOS SANITARIOS

49

50 CONCLUSIONS

51 GRACIAS